Literature DB >> 1377508

Embedding and fixation techniques for immunohistochemical staining with anti-DNA polymerase alpha and Ki-67 monoclonal antibodies to analyze the proliferative potential of tumors.

M Shibuya1, T Miwa, T Hoshino.   

Abstract

Anti-DNA polymerase alpha and Ki-67 are monoclonal antibodies that recognize nuclear antigens expressed in proliferating cells. In this study, we evaluated various methods of embedding and fixing brain tumor specimens to optimize staining with these antibodies. In fresh frozen sections, postfixation with 4% paraformaldehyde, 100% methanol, 95% ethanol and 10% buffered formalin were tested; also tested were prefixation with 4% paraformaldehyde followed by freezing and fixation with 100% methanol, 95% ethanol, or 10% buffered formalin followed by embedding in paraffin. For both antibodies, postfixation of fresh frozen sections with 4% paraformaldehyde at 4 C gave the most intense staining and lowest background activity while preserving histological features. This technique can be used in routine clinical practice to predict the growth potential of tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377508     DOI: 10.3109/10520299209110028

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  3 in total

1.  Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.

Authors:  M Shibuya; F Saito; T Miwa; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Endothelial cell implantation and survival within experimental gliomas.

Authors:  B Lal; R R Indurti; P O Couraud; G W Goldstein; J Laterra
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

3.  Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.

Authors:  V Waldmann; H M Rabes
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.